Ligand Pharmaceuticals Incorporated (LGND)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
As of 02:47PM EDT. Market open.
| Previous Close | 72.32 |
| Open | 73.53 |
| Bid | 73.30 x 100 |
| Ask | 73.93 x 100 |
| Day's Range | 72.57 - 73.99 |
| 52 Week Range | 49.24 - 94.57 |
| Volume | |
| Avg. Volume | 179,366 |
| Market Cap | 1.319B |
| Beta (5Y Monthly) | 0.92 |
| PE Ratio (TTM) | 24.24 |
| EPS (TTM) | 3.03 |
| Earnings Date | May 07, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Jul 02, 2010 |
| 1y Target Est | 116.80 |
ZacksAgios (AGIO) Q1 Earnings Surpass, Sales Miss Estimates
Agios (AGIO) reports mixed earnings results for first-quarter 2024. Though sales miss the mark, revenues from its sole marketed drug, Pyrukynd, rise sequentially and on a yearly basis.
ZacksBlueprint (BPMC) Q1 Earnings and Revenues Beat, Stock Rises
Blueprint (BPMC) gains from better-than-expected first-quarter 2024 results, driven by robust Ayvakit sales growth. The company raises its revenue guidance for 2024.
ZacksZoetis (ZTS) Q1 Earnings and Revenues Surpass Estimates
Zoetis (ZTS) reports better-than-expected first-quarter results, wherein both earnings and revenues beat estimates. Shares rise.
© 2024 Yahoo. All rights reserved.